BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12691918)

  • 21. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia.
    Natarajan C; Sriram S; Muthian G; Bright JJ
    Glia; 2004 Jan; 45(2):188-96. PubMed ID: 14730712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
    Selvaraj NG; Omi E; Gibori G; Rao MC
    Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production.
    Versteeg HH; Spek CA; Slofstra SH; Diks SH; Richel DJ; Peppelenbosch MP
    Circ Res; 2004 Apr; 94(8):1032-40. PubMed ID: 15016732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.
    Christensen JG; Zou HY; Arango ME; Li Q; Lee JH; McDonnell SR; Yamazaki S; Alton GR; Mroczkowski B; Los G
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3314-22. PubMed ID: 18089725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
    Leventaki V; Drakos E; Medeiros LJ; Lim MS; Elenitoba-Johnson KS; Claret FX; Rassidakis GZ
    Blood; 2007 Sep; 110(5):1621-30. PubMed ID: 17416736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells.
    Zhang XF; Wang JF; Matczak E; Proper JA; Groopman JE
    Blood; 2001 Jun; 97(11):3342-8. PubMed ID: 11369622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).
    Ouyang T; Bai RY; Bassermann F; von Klitzing C; Klumpen S; Miething C; Morris SW; Peschel C; Duyster J
    J Biol Chem; 2003 Aug; 278(32):30028-36. PubMed ID: 12748172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) modulates lactogenic hormone-mediated differentiation and gene expression in HC11 mouse mammary epithelial cells.
    Shan L; Rouhani SA; Schut HA; Snyderwine EG
    Cell Growth Differ; 2001 Dec; 12(12):649-56. PubMed ID: 11751460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling.
    Ho JM; Beattie BK; Squire JA; Frank DA; Barber DL
    Blood; 1999 Jun; 93(12):4354-64. PubMed ID: 10361134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
    Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S
    Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
    Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
    Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming.
    Marzec M; Halasa K; Liu X; Wang HY; Cheng M; Baldwin D; Tobias JW; Schuster SJ; Woetmann A; Zhang Q; Turner SD; Ă˜dum N; Wasik MA
    J Immunol; 2013 Dec; 191(12):6200-7. PubMed ID: 24218456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stat 5B, activated by insulin in a Jak-independent fashion, plays a role in glucokinase gene transcription.
    Sawka-Verhelle D; Tartare-Deckert S; Decaux JF; Girard J; Van Obberghen E
    Endocrinology; 2000 Jun; 141(6):1977-88. PubMed ID: 10830280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.
    Amin HM; Medeiros LJ; Ma Y; Feretzaki M; Das P; Leventaki V; Rassidakis GZ; O'Connor SL; McDonnell TJ; Lai R
    Oncogene; 2003 Aug; 22(35):5399-407. PubMed ID: 12934099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a.
    Gu TL; Tothova Z; Scheijen B; Griffin JD; Gilliland DG; Sternberg DW
    Blood; 2004 Jun; 103(12):4622-9. PubMed ID: 14962911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner.
    Si J; Collins SJ
    Blood; 2002 Dec; 100(13):4401-9. PubMed ID: 12393611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R
    Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.
    Kirito K; Watanabe T; Sawada K; Endo H; Ozawa K; Komatsu N
    J Biol Chem; 2002 Mar; 277(10):8329-37. PubMed ID: 11756417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.
    Chiarle R; Gong JZ; Guasparri I; Pesci A; Cai J; Liu J; Simmons WJ; Dhall G; Howes J; Piva R; Inghirami G
    Blood; 2003 Mar; 101(5):1919-27. PubMed ID: 12424201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.